Product Code: TMRGL344
TMR's report on the global contraceptives market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global contraceptives market for the period 2017-2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global contraceptives market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global contraceptives market.
The report delves into the competition landscape of the global contraceptives market. Key players operating in the global contraceptives market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global contraceptives market that have been profiled in this report.
Key Questions Answered:
- What is the scope of growth of product companies in the global contraceptives market?
- What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
- What is the influence of changing trends in technologies on the global contraceptives market?
- Will North America to be the most profitable market for contraceptives devices providers?
- Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
- Which are the leading companies in the global contraceptives market?
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Contraceptives Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Key Market Indicators
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.2. Restraints
- 4.4.3. Opportunity
- 4.5. Global Contraceptives Market Analysis and Forecast, 2017-2028
- 4.5.1. Market Revenue Projections (US$ Mn)
- 4.6. Global Contraceptives Market - Global Supply Demand Scenario
- 4.7. Porter's Five Force Analysis
- 4.8. Value Chain Analysis
- 4.9. Market Outlook
5. Global Contraceptives Market Analysis and Forecast, By Product
- 5.1. Introduction & Definition
- 5.2. Key Findings / Developments
- 5.3. Key Trends
- 5.4. Market Value Forecast, by Product, 2017-2028
- 5.4.1. Contraceptives Drugs
- 5.4.1.1. Oral Contraceptives
- 5.4.1.1.1. Combined Contraceptives
- 5.4.1.1.2. Mini-pills
- 5.4.1.2. Contraceptive Injectable
- 5.4.1.3. Topical Contraceptive Patch
- 5.4.2. Contraceptive Devices
- 5.4.2.1. Male Contraceptive Devices
- 5.4.2.2. Female Contraceptive Devices
- 5.4.2.2.1. Female Condoms
- 5.4.2.2.2. Contraceptive Diaphragms
- 5.4.2.2.3. Contraceptive Sponges
- 5.4.2.2.4. Contraceptive Vaginal Rings
- 5.4.2.2.5. Intrauterine Devices
- 5.4.2.2.6. Sub-dermal Contraceptives Implants
- 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
- 5.5. Market Attractiveness Analysis, By Product
6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Key Trends
- 6.4. Market Value Forecast, by Distribution Channel, 2017-2028
- 6.4.1. Hospital Pharmacy
- 6.4.1.1. Public
- 6.4.1.2. Private
- 6.4.2. Independent Pharmacy
- 6.4.3. Online Platform
- 6.4.4. Clinics
- 6.4.5. Others
- 6.5. Market Attractiveness Analysis, By Distribution Channel
7. Global Contraceptives Market Analysis and Forecast, By Region
- 7.1. Key Findings
- 7.2. Policies and Regulations
- 7.3. Market Value Forecast, by Region
- 7.3.1. North America
- 7.3.2. Europe
- 7.3.3. Asia Pacific
- 7.3.4. Latin America
- 7.3.5. Middle East and Africa
- 7.4. Market Attractiveness Analysis, By Country/Region
8. North America Contraceptives Market Analysis and Forecast
- 8.1. Introduction
- 8.1.1. Key Findings
- 8.1.2. Policies and Regulations
- 8.1.3. Key Trends
- 8.2. Market Value Forecast, by Product, 2017-2028
- 8.2.1. Contraceptive Drugs
- 8.2.1.1. Oral Contraceptives
- 8.2.1.1.1. Combined Contraceptives
- 8.2.1.1.2. Mini-pills
- 8.2.1.2. Contraceptive Injectable
- 8.2.1.3. Topical Contraceptive Patch
- 8.2.2. Contraceptive Devices
- 8.2.2.1. Male Contraceptive Devices
- 8.2.2.2. Female Contraceptive Devices
- 8.2.2.2.1. Female Condoms
- 8.2.2.2.2. Contraceptive Diaphragms
- 8.2.2.2.3. Contraceptive Sponges
- 8.2.2.2.4. Contraceptive Vaginal Rings
- 8.2.2.2.5. Intrauterine Devices
- 8.2.2.2.6. Sub-dermal Contraceptives Implants
- 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
- 8.3. Market Value Forecast, by Distribution Channel, 2017-2028
- 8.3.1. Hospital Pharmacy
- 8.3.1.1. Public
- 8.3.1.2. Private
- 8.3.2. Independent Pharmacy
- 8.3.3. Online Platform
- 8.3.4. Clinics
- 8.3.5. Others
- 8.4. Market Value Forecast, by Country, 2017-2028
- 8.4.1. U.S.
- 8.4.2. Canada
- 8.5. Market Attractiveness Analysis
- 8.5.1. By Product
- 8.5.2. By Distribution Channel
- 8.5.3. By Country
9. Europe Contraceptives Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.1.2. Policies and Regulations
- 9.1.3. Key Trends
- 9.2. Market Value Forecast, by Product, 2017-2028
- 9.2.1. Contraceptive Drugs
- 9.2.1.1. Oral Contraceptives
- 9.2.1.1.1. Combined Contraceptives
- 9.2.1.1.2. Mini-pills
- 9.2.1.2. Contraceptive Injectable
- 9.2.1.3. Topical Contraceptive Patch
- 9.2.2. Contraceptive Devices
- 9.2.2.1. Male Contraceptive Devices
- 9.2.2.2. Female Contraceptive Devices
- 9.2.2.2.1. Female Condoms
- 9.2.2.2.2. Contraceptive Diaphragms
- 9.2.2.2.3. Contraceptive Sponges
- 9.2.2.2.4. Contraceptive Vaginal Rings
- 9.2.2.2.5. Intrauterine Devices
- 9.2.2.2.6. Sub-dermal Contraceptives Implants
- 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
- 9.3. Market Value Forecast, by Distribution Channel, 2017-2028
- 9.3.1. Hospital Pharmacy
- 9.3.1.1. Public
- 9.3.1.2. Private
- 9.3.2. Independent Pharmacy
- 9.3.3. Online Platform
- 9.3.4. Clinics
- 9.3.5. Others
- 9.4. Market Value Forecast, by Country/Sub-region, 2017-2028
- 9.4.1. Germany
- 9.4.2. France
- 9.4.3. U.K.
- 9.4.4. Spain
- 9.4.5. Italy
- 9.4.6. Russia
- 9.4.7. Rest of Europe
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By Distribution Channel
- 9.5.3. By Country/Sub-region
10. Asia Pacific Contraceptives Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.1.2. Policies and Regulations
- 10.1.3. Key Trends
- 10.2. Market Value Forecast, by Product, 2017-2028
- 10.2.1. Contraceptive Drugs
- 10.2.1.1. Oral Contraceptives
- 10.2.1.1.1. Combined Contraceptives
- 10.2.1.1.2. Mini-pills
- 10.2.1.2. Contraceptive Injectable
- 10.2.1.3. Topical Contraceptive Patch
- 10.2.2. Contraceptive Devices
- 10.2.2.1. Male Contraceptive Devices
- 10.2.2.2. Female Contraceptive Devices
- 10.2.2.2.1. Female Condoms
- 10.2.2.2.2. Contraceptive Diaphragms
- 10.2.2.2.3. Contraceptive Sponges
- 10.2.2.2.4. Contraceptive Vaginal Rings
- 10.2.2.2.5. Intrauterine Devices
- 10.2.2.2.6. Sub-dermal Contraceptives Implants
- 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
- 10.3. Market Value Forecast, by Distribution Channel, 2017-2028
- 10.3.1. Hospital Pharmacy
- 10.3.1.1. Public
- 10.3.1.2. Private
- 10.3.2. Independent Pharmacy
- 10.3.3. Online Platforms
- 10.3.4. Clinics
- 10.3.5. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2028
- 10.4.1. China
- 10.4.2. Japan
- 10.4.3. India
- 10.4.4. Australia & New Zealand
- 10.4.5. Rest of Asia Pacific
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Product
- 10.5.2. By Distribution Channel
- 10.5.3. By Country/Sub-region
11. Latin America Contraceptives Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.1.2. Policies and Regulations
- 11.1.3. Key Trends
- 11.2. Market Value Forecast, by Product, 2017-2028
- 11.2.1. Contraceptive Drugs
- 11.2.1.1. Oral Contraceptives
- 11.2.1.1.1. Combined Contraceptives
- 11.2.1.1.2. Mini-pills
- 11.2.1.2. Contraceptive Injectable
- 11.2.1.3. Topical Contraceptive Patch
- 11.2.2. Contraceptive Devices
- 11.2.2.1. Male Contraceptive Devices
- 11.2.2.2. Female Contraceptive Devices
- 11.2.2.2.1. Female Condoms
- 11.2.2.2.2. Contraceptive Diaphragms
- 11.2.2.2.3. Contraceptive Sponges
- 11.2.2.2.4. Contraceptive Vaginal Rings
- 11.2.2.2.5. Intrauterine Devices
- 11.2.2.2.6. Sub-dermal Contraceptives Implants
- 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
- 11.3. Market Value Forecast, by Distribution Channel, 2017-2028
- 11.3.1. Hospital Pharmacy
- 11.3.1.1. Public
- 11.3.1.2. Private
- 11.3.2. Independent Pharmacy
- 11.3.3. Online Platforms
- 11.3.4. Clinics
- 11.3.5. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2028
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Product
- 11.5.2. By Distribution Channel
- 11.5.3. By Country/Sub-region
12. Middle East and Africa Contraceptives Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.1.2. Policies and Regulations
- 12.1.3. Key Trends
- 12.2. Market Value Forecast, by Product, 2017-2028
- 12.2.1. Contraceptive Drugs
- 12.2.1.1. Oral Contraceptives
- 12.2.1.1.1. Combined Contraceptives
- 12.2.1.1.2. Mini-pills
- 12.2.1.2. Contraceptive Injectable
- 12.2.1.3. Topical Contraceptive Patch
- 12.2.2. Contraceptive Devices
- 12.2.2.1. Male Contraceptive Devices
- 12.2.2.2. Female Contraceptive Devices
- 12.2.2.2.1. Female Condoms
- 12.2.2.2.2. Contraceptive Diaphragms
- 12.2.2.2.3. Contraceptive Sponges
- 12.2.2.2.4. Contraceptive Vaginal Rings
- 12.2.2.2.5. Intrauterine Devices
- 12.2.2.2.6. Sub-dermal Contraceptives Implants
- 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
- 12.3. Market Value Forecast, by End User, 2017-2028
- 12.3.1. Hospital Pharmacy
- 12.3.1.1. Public
- 12.3.1.2. Private
- 12.3.2. Independent Pharmacy
- 12.3.3. Online Platform
- 12.3.4. Clinics
- 12.3.5. Others
- 12.4. Market Value Forecast, by Country /Sub-region, 2017-2028
- 12.4.1. GCC Countries
- 12.4.2. South Africa
- 12.4.3. Rest of Middle East and Africa
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Product
- 12.5.2. By Distribution Channel
- 12.5.3. By Country/Sub-region
13. Competition Landscape
- 13.1. Market Player - Competition Matrix (by tier and size of companies)
- 13.2. Market Share Analysis, by Company, 2020
- 13.3. Company Profiles
- 13.3.1. Merck & Co., Inc.
- 13.3.1.1. Overview
- 13.3.1.2. Financials
- 13.3.1.3. Recent Developments
- 13.3.1.4. Strategy
- 13.3.2. Cipla, Inc.
- 13.3.2.1. Overview
- 13.3.2.2. Financials
- 13.3.2.3. Recent Developments
- 13.3.2.4. Strategy
- 13.3.3. Allergan plc
- 13.3.3.1. Overview
- 13.3.3.2. Financials
- 13.3.3.3. Recent Developments
- 13.3.3.4. Strategy
- 13.3.4. Bayer AG
- 13.3.4.1. Overview
- 13.3.4.2. Financials
- 13.3.4.3. Recent Developments
- 13.3.4.4. Strategy
- 13.3.5. HLL Lifecare Limited
- 13.3.5.1. Overview
- 13.3.5.2. Financials
- 13.3.5.3. Recent Developments
- 13.3.5.4. Strategy
- 13.3.6. Mankind Pharma
- 13.3.6.1. Overview
- 13.3.6.2. Financials
- 13.3.6.3. Recent Developments
- 13.3.6.4. Strategy
- 13.3.7. Pfizer, Inc.
- 13.3.7.1. Overview
- 13.3.7.2. Financials
- 13.3.7.3. Recent Developments
- 13.3.7.4. Strategy
- 13.3.8. Teva Pharmaceutical Industries Ltd.
- 13.3.8.1. Overview
- 13.3.8.2. Financials
- 13.3.8.3. Recent Developments
- 13.3.8.4. Strategy
- 13.3.9. Mithra Pharmaceuticals
- 13.3.9.1. Overview
- 13.3.9.2. Financials
- 13.3.9.3. Recent Developments
- 13.3.9.4. Strategy
- 13.3.10. Janssen Pharmaceutical Company
- 13.3.10.1. Overview
- 13.3.10.2. Financials
- 13.3.10.3. Recent Developments
- 13.3.10.4. Strategy
- 13.3.11. Reckitt Benckiser Group plc
- 13.3.11.1. Overview
- 13.3.11.2. Financials
- 13.3.11.3. Recent Developments
- 13.3.11.4. Strategy